Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays

Molecular and Cellular Proteomics

Volumn 12, Issue 9, 2013, Pages 2615-2622

  Assadi, Maziar ^a   Lamerz, Jens ^a   Jarutat, Tiantom ^b   Farfsing, Alexandra ^b   Paul, Hubert ^b   Gierke, Berthold ^c   Breitinger, Ewa ^c   Templin, Markus F ^c   Essioux, Laurent ^a   Arbogast, Susanne ^b   Venturi, Miro ^b   Pawlak, Michael ^c   Langen, Hanno ^a   Schindler, Thomas ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; P21 ACTIVATED KINASE 2; PARAFFIN;

ADENOCARCINOMA; ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVERSE PHASE PROTEIN ARRAY; SQUAMOUS CELL CARCINOMA; TISSUE FIXATION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROTEIN ARRAY ANALYSIS; RECEPTOR, ERBB-2; STAINING AND LABELING; TISSUE FIXATION;

EID: 84884369416     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.023051     Document Type: Article

References (48)

1. Hopkins, A. L. (2008) Network pharmacology: the next paradigm in drug discovery. Nat. Chem. Biol. 4, 682-690
2. Malinowsky, K., Wolff, C., Ergin, B., Berg, D., and Becker, K. F. (2010) Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J. Cell. Physiol. 225, 364-370
3. Wilson, B., Liotta, L. A., and Petricoin, E., 3rd (2010) Monitoring proteins and protein networks using reverse phase protein arrays. Dis. Markers 28, 225-232
4. Voshol, H., Ehrat, M., Traenkle, J., Bertrand, E., and van Oostrum, J. (2009) Antibody-based proteomics: analysis of signaling networks using reverse protein arrays. FEBS J. 276, 6871-6879
5. Becker, K. F., Schott, C., Hipp, S., Metzger, V., Porschewski, P., Beck, R., Nahrig, J., Becker, I., and Höfler, H. (2007) Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 211, 370-378 (Pubitemid 46172713)
6. Chu, W. S., Liang, Q., Liu, J., Wei, M. Q., Winters, M., Liotta, L., Sandberg, G., and Gong, M. (2005) A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section. Lab. Invest. 85, 1416-1428 (Pubitemid 41509389)
7. Ikeda, K., Monden, T., Kanoh, T., Tsujie, M., Izawa, H., Haba, A., Ohnishi, T., Sekimoto, M., Tomita, N., Shiozaki, H., and Monden, M. (1998) Extraction and analysis of diagnostically useful proteins from formalinfixed, paraffin-embedded tissue sections. J. Histochem. Cytochem. 46, 397-403 (Pubitemid 28117390)
8. Nirmalan, N. J., Harnden, P., Selby, P. J., and Banks, R. E. (2009) Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J. Pathol. 217, 497-506
9. Chung, J. Y., Lee, S. J., Kris, Y., Braunschweig, T., Traicoff, J. L., and Hewitt, S. M. (2008) A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue. Proteomics Clin. Appl. 2, 1539-1547
10. Shi, S. R., Liu, C., Balgley, B. M., Lee, C., and Taylor, C. R. (2006) Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J. Histochem. Cytochem. 54, 739-743 (Pubitemid 43736896)
11. Becker, K. F., Schott, C., Becker, I., and Höfler, H. (2008) Guided protein extraction from formalin-fixed tissues for quantitative multiplex analysis avoids detrimental effects of histological stains. Proteomics Clin. Appl. 2, 737-743 (Pubitemid 351772028)
12. Addis, M. F., Tanca, A., Pagnozzi, D., Crobu, S., Fanciulli, G., Cossu-Rocca, P., and Uzzau, S. (2009) Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 9, 3815-3823
13. Nirmalan, N. J., Harnden, P., Selby, P. J., and Banks, R. E. (2009) Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using Western blotting. J. Pathol. 217, 497-506
14. Wolff, A. C., Hammon, E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., McShane, L. M., Paik, S., Pegram, M. D., Perez, E. A., Press, M. F., Rhodes, A., Sturgeon, C., Taube, S. E., Tubbs, R., Vance, G. H., van de Vijver, M., Wheeler, T. M., and Hayes, D. F. (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch. Pathol. Lab. Med. 131, 18-43 (Pubitemid 46174133)
15. Pawlak, M., Schick, E., Bopp, M. A., Schneider, M. J., Oroszlan, P., and Ehrat, M. (2002) Zeptosens' protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics 2, 383-393 (Pubitemid 34429356)
16. R Development Core Team (2008) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria
17. Gamer, M., Lemon, J., and Fellows, I. (2009) irr: Various Coefficients of Interrater Reliability and Agreement, R package version 0.82 R Foundation for Statistical Computing, Vienna, Austria
18. Venables, W. N., and Ripley, B. D. (2002) Modern Applied Statistics with S, Springer, New York
19. Faraway, J. J. (2006) Extending the Linear Model with R: Generalized Linear, Mixed Effects and Nonparametric Regression Models, Chapman & Hall/CRC, Boca Raton, FL
20. Agresti, A. (2007) An Introduction to Categorical Data Analysis, Wiley Series in Probability and Statistics, Wiley-Interscience, Hoboken, NJ
21. Bates, D., Maechler, M., and Bolker, B. (2011) lme4: Linear Mixed-effects Models Using S4 classes, R package version 0.999375-42 R Foundation for Statistical Computing, Vienna, Austria
22. Mukhopadhyay, S., and Katzenstein, A. L. (2011) Subclassification of nonsmall cell lung carcinomas lacking morphological differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am. J. Surg. Pathol. 35, 15-25
23. Navolanic, P. M., Steelman, L. S., and McCubrey, J. A. (2003) EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (review). Int. J. Oncol. 22, 237-252
24. Ross, J. S., Fletcher, J. A., Bloom, K. J., Linette, G. P., Stec, J., Symmans, W. F., Pusztai, L., and Hortobagyi, G. N. (2004) Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol. Cell. Proteomics 3, 379-398 (Pubitemid 38702091)
25. Hayes, D. F., and Thor, A. D. (2002) c-erbB-2 in breast cancer: development of a clinically useful marker. Semin. Oncol. 29, 231-245 (Pubitemid 34620440)
26. Masood, S., and Bui, M. M. (2002) Prognostic and predictive value of HER2/neu oncogene in breast cancer. Microsc. Res. Tech. 59, 102-108 (Pubitemid 35154912)
27. Schnitt, S. J., and Jacobs, T. W. (2001) Current status of HER2 testing: caught between a rock and a hard place. Am. J. Clin. Pathol. 116, 806-810 (Pubitemid 33108149)
28. Kay, E. W., Walsh, C. J., Cassidy, M., Curran, B., and Leader, M. (1994) C-erbB-2 immunostaining: problems with interpretation. J. Clin. Pathol. 47, 816-822
29. Thomson, T. A., Hayes, M. M., Spinelli, J. J., Hilland, E., Sawrenko, C., Phillips, D., Dupuis, B., and Parker, R. L. (2001) HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod. Pathol. 14, 1079-1086 (Pubitemid 33063199)
30. Seelig, S. (1999) Fluorescence in situ hybridization versus immunohistochemistry: importance of clinical outcome. J. Clin. Oncol. 17, 3690-3692 (Pubitemid 29517944)
31. Lal, P., Salazar, P. A., Hudis, C. A., Ladanyi, M., and Chen, B. (2004) HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring. Am. J. Clin. Pathol. 121, 631-636 (Pubitemid 38533994)
32. Owens, M. A., Horten, B. C., and Da Silva, M. M. (2004) HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin. Breast Cancer 5, 63-69 (Pubitemid 38821193)
33. Press, M. F., Sauter, G., Bernstein, L., Villalobos, I. E., Mirlacher, M., Zhou, J. Y., Wardeh, R., Li, Y. T., Guzman, R., Ma, Y., Sullivan-Halley, J., Santiago, A., Park, J. M., Riva, A., and Slamon, D. J. (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin. Cancer Res. 11, 6598-6607 (Pubitemid 41339000)
34. Tubbs, R. R., Hicks, D. G., Cook, J., Downs-Kelly, E., Pettay, J., Hartke, M. B., Hood, L., Neelon, R., Myles, J., Budd, G. T., Moore, H. C., Andresen, S., and Crowe, J. P. (2007) Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast: a single institution experience. Diagn. Mol. Pathol. 16, 207-210 (Pubitemid 350196977)
35. Ross, J. S., Symmans, W. F., Pusztai, L., and Hortobagyi, G. N. (2007) Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes. Clin. Cancer Res. 13, 2831-2835 (Pubitemid 46849556)
36. Dendukuri, N., Khetani, K., McIsaac, M., and Brophy, J. (2007) Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis. CMA J. 176, 1429-1434 (Pubitemid 46762020)
37. Carlson, R. W., Moench, S. J., Hammond, M. E., Perez, E. A., Burstein, H. J., Allred, D. C., Vogel, C. L., Goldstein, L. J., Somlo, G., Gradishar, W. J., Hudis, C. A., Jahanzeb, M., Stark, A., Wolff, A. C., Press, M. F., Winer, E. P., Paik, S., and Ljung, B. M. (2006) HER2 testing in breast cancer: NCCN Task Force report and recommendations. J. Natl. Compr. Canc. Netw. 4 Suppl 3, S1-S22
38. Cuadros, M., and Villegas, R. (2009) Systematic review of HER2 breast cancer testing. Appl. Immunohistochem. Mol. Morphol. 17, 1-7
39. Perez, E. A., and Baweja, M. (2008) HER2-positive breast cancer: current treatment strategies. Cancer Invest. 26, 545-552 (Pubitemid 351918580)
40. Hicks, D. G., and Kulkarni, S. (2008) Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing. Arch. Pathol. Lab. Med. 132, 1008-1015 (Pubitemid 351918709)
41. Wulfkuhle, J. D., Berg, D., Wolff, C., Langer, R., Tran, K., Illi, J., Espina, V., Pierobon, M., Deng, J., DeMichele, A., Walch, A., Bronger, H., Becker, I., Waldhör, C., Höfler, H., Esserman, L; I-SPY 1 TRIAL Investigators, Liotta, L. A., Becker, K.-F., and Petricoin, E. F. (2012) Molecular analysis of HER2 breast cancer by functional protein pathway activation mapping. Clin. Cancer Res. 18, 6426-6435
42. Kumar, R., and Vadlamudi, R. K. (2002) Emerging functions of p21-Activated kinases in human cancer cells. J. Cell. Physiol. 193, 133-144
43. Carter, J. H., Douglass, L. E., Deddens, J. A., Colligan, B. M., Bhatt, T. R., Pemberton, J. O., Konicek, S., Hom, J., Marshall, M., and Graff, J. R. (2004) Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin. Cancer Res. 10, 3448-3456 (Pubitemid 38685452)
44. Holm, C., Rayala, S., Jirström, K., Stal, O., Kumar, R., and Landberg, G. (2006) Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J. Natl. Cancer Inst. 98, 671-680 (Pubitemid 43821785)
45. Ong, C. C., Jubb, A. M., Haverty, P. M., Zhou, W., Tran, V., Truong, T., Turley, H., O'Brien, T., Vucic, D., Harris, A. L., Belvin, M., Friedman, L. S., Blackwood, E. M., Koeppen, H., and Hoeflich, K. P. (2011) Targeting p21-Activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proc. Natl. Acad. Sci. U.S.A. 108, 7177-7182
46. Jakobi, R., Moertl, E., and Koeppel, M. A. (2001) p21-Activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276, 16624-16634
47. Rudel, T., and Bokoch, G. M. (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574 (Pubitemid 27255323)
48. Jakobi, R., McCarthy, C. C., Koeppel, M. A., and Stringer, D. K. (2003) Caspase-Activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J. Biol. Chem. 278, 38675-38685 (Pubitemid 37221764)